减压
头孢吡肟
内科学
医学
肺炎
菌血症
突变
血流感染
生产过剩
微生物学
抗生素
生物
遗传学
抗生素耐药性
亚胺培南
基因
心理压抑
基因表达
作者
Alexis Maillard,Laurent Dortet,Tristan Delory,Matthieu Lafaurie,Alexandre Bleibtreu,for the Treatment of AmpC producing Enterobacterales study group,Élie Azoulay,Adrien Joseph,Jean‐Michel Molina,Matthieu Lafaurie,Béatrice Berçot,Alexis Maillard,Olivier Paccoud,Alexandre Bleibtreu,Jérome Robert,Laurence Drieux,Juliette Bernier,Antoine Villa,Éric Maury,Laure Surgers
摘要
In a retrospective multicenter study of 575 patients with bloodstream infections or pneumonia due to wild-type AmpC β-lactamase-producing Enterobacterales, species with low in vitro mutation rates for AmpC derepression were associated with fewer treatment failures due to AmpC overproduction (adjusted hazard ratio, 0.5 [95% CI, .2-.9]). However, compared to cefepime/carbapenems, using third-generation cephalosporins as definitive therapy remained associated with this adverse outcome (15% vs 1%).
科研通智能强力驱动
Strongly Powered by AbleSci AI